A concordance study of subareolar and subdermal injections for breast cancer sentinel lymph node mapping

Richard J. Gray, Barbara A Pockaj

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

There is disagreement regarding the preferred injection site for breast sentinel lymph node mapping. The concordance of blue staining and radioactivity in the sentinel nodes of 730 consecutive patients was analyzed based on injection of mapping agents into the same or separate intradermal and subareolar sites. There were no significant differences in identification rates or the mean number of sentinel nodes whether agents were injected into the same or separate sites. In each group, a concordant sentinel node (both blue and "hot") was identified in >90% of patients (P = not significant). There were no significant differences in the percentage of sentinel nodes identified as both blue and hot. Separate subdermal and subareolar injections of mapping agents drain to the same sentinel node as often as injections into the same location. These two injection techniques appear to result in the identification of the same sentinel nodes.

Original languageEnglish (US)
Pages (from-to)423-425
Number of pages3
JournalAmerican Journal of Surgery
Volume188
Issue number4 SPEC. ISS.
DOIs
StatePublished - Oct 2004

Fingerprint

Breast Neoplasms
Injections
Radioactivity
Sentinel Lymph Node
cyhalothrin
Breast
Staining and Labeling

Keywords

  • Breast Cancer
  • Concordance
  • Sentinel Node
  • Technique

ASJC Scopus subject areas

  • Surgery

Cite this

A concordance study of subareolar and subdermal injections for breast cancer sentinel lymph node mapping. / Gray, Richard J.; Pockaj, Barbara A.

In: American Journal of Surgery, Vol. 188, No. 4 SPEC. ISS., 10.2004, p. 423-425.

Research output: Contribution to journalArticle

@article{2e450934d546498e881db87df3bf38e6,
title = "A concordance study of subareolar and subdermal injections for breast cancer sentinel lymph node mapping",
abstract = "There is disagreement regarding the preferred injection site for breast sentinel lymph node mapping. The concordance of blue staining and radioactivity in the sentinel nodes of 730 consecutive patients was analyzed based on injection of mapping agents into the same or separate intradermal and subareolar sites. There were no significant differences in identification rates or the mean number of sentinel nodes whether agents were injected into the same or separate sites. In each group, a concordant sentinel node (both blue and {"}hot{"}) was identified in >90{\%} of patients (P = not significant). There were no significant differences in the percentage of sentinel nodes identified as both blue and hot. Separate subdermal and subareolar injections of mapping agents drain to the same sentinel node as often as injections into the same location. These two injection techniques appear to result in the identification of the same sentinel nodes.",
keywords = "Breast Cancer, Concordance, Sentinel Node, Technique",
author = "Gray, {Richard J.} and Pockaj, {Barbara A}",
year = "2004",
month = "10",
doi = "10.1016/j.amjsurg.2004.06.018",
language = "English (US)",
volume = "188",
pages = "423--425",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "4 SPEC. ISS.",

}

TY - JOUR

T1 - A concordance study of subareolar and subdermal injections for breast cancer sentinel lymph node mapping

AU - Gray, Richard J.

AU - Pockaj, Barbara A

PY - 2004/10

Y1 - 2004/10

N2 - There is disagreement regarding the preferred injection site for breast sentinel lymph node mapping. The concordance of blue staining and radioactivity in the sentinel nodes of 730 consecutive patients was analyzed based on injection of mapping agents into the same or separate intradermal and subareolar sites. There were no significant differences in identification rates or the mean number of sentinel nodes whether agents were injected into the same or separate sites. In each group, a concordant sentinel node (both blue and "hot") was identified in >90% of patients (P = not significant). There were no significant differences in the percentage of sentinel nodes identified as both blue and hot. Separate subdermal and subareolar injections of mapping agents drain to the same sentinel node as often as injections into the same location. These two injection techniques appear to result in the identification of the same sentinel nodes.

AB - There is disagreement regarding the preferred injection site for breast sentinel lymph node mapping. The concordance of blue staining and radioactivity in the sentinel nodes of 730 consecutive patients was analyzed based on injection of mapping agents into the same or separate intradermal and subareolar sites. There were no significant differences in identification rates or the mean number of sentinel nodes whether agents were injected into the same or separate sites. In each group, a concordant sentinel node (both blue and "hot") was identified in >90% of patients (P = not significant). There were no significant differences in the percentage of sentinel nodes identified as both blue and hot. Separate subdermal and subareolar injections of mapping agents drain to the same sentinel node as often as injections into the same location. These two injection techniques appear to result in the identification of the same sentinel nodes.

KW - Breast Cancer

KW - Concordance

KW - Sentinel Node

KW - Technique

UR - http://www.scopus.com/inward/record.url?scp=4944229654&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4944229654&partnerID=8YFLogxK

U2 - 10.1016/j.amjsurg.2004.06.018

DO - 10.1016/j.amjsurg.2004.06.018

M3 - Article

C2 - 15474440

AN - SCOPUS:4944229654

VL - 188

SP - 423

EP - 425

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 4 SPEC. ISS.

ER -